MedTrace Logo

Non-alcoholic Steatohepatitis Registry Platform Study

NCT06123858 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1122

Last updated 2025-12-18

No results posted yet for this study

Summary

This is a multi-center, prospective, observational registry platform study aimed at describing the clinical characteristics and diagnosis and treatment patterns of Chinese patients with nonalcoholic steatohepatitis (NASH) with fibrosis.

Conditions

  • NASH With Fibrosis

Sponsors & Collaborators

Principal Investigators

  • Lai Wei · Hepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, Tsinghua University

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-22
Primary Completion
2025-10-17
Completion
2025-10-17

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06123858 on ClinicalTrials.gov